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The metabolic syndrome (MS) is a cluster of risk factors: diabetes and prediabetes,abdominal obesity,dyslipidemia and high blood pressure [1] . Late-onset hypogonadism (LOH) in men is clinical and biochemical age-related syndrome that is characterised by a number of clinical symptoms and low testosterone
The MS and the control groups were similar in age and height but consistently differed by their weight (p<0.001), BMI (p<0.001), waist circumference (p<0.001) and hip circumference (p<0.001), waist-tohip ratio (p<0.001). Defining the subgroups by TT-levels, more than 30% of the MS patients were hypogonadal. In this study the difference in apelin levels was related to the presence of the MS, but not to the TT status diagnosed: neuropathy had 77.5%; retinopathy -26.5% (30% of them-proliferative) and only 2% had nephropathy.
Hypertension was part of the MS in 71% of the patients and almost all of them had already been assigned to antihypertensive medication. 32% of the controls were also hypertensive.
Lipid-lowering medication had already been prescribed to 25% of the MS-patients. After prescribed to 25% of the MS-patients. After laboratory evaluation more than 50% had low HDL, in more than 50% high triglycerides were established, and 27% had both lipid abnormalities. into two groups: MS-LOH (N=21) and MSnoLOH (N=44). The control group consisted of 34 age-matched men without MS and LOH. Apelin was determined in serum using enzymelinked immunosorbent assay.
